Kestra Advisory Services’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.08M | Buy |
29,522
+4,772
| +19% | +$174K | 0.01% | 1425 |
|
2025
Q1 | $956K | Sell |
24,750
-4,626
| -16% | -$179K | ﹤0.01% | 1415 |
|
2024
Q4 | $1.11M | Buy |
29,376
+4,460
| +18% | +$169K | 0.01% | 1352 |
|
2024
Q3 | $1.04M | Sell |
24,916
-3,307
| -12% | -$139K | 0.01% | 1298 |
|
2024
Q2 | $1.15M | Sell |
28,223
-523
| -2% | -$21.4K | 0.01% | 1234 |
|
2024
Q1 | $1.19M | Sell |
28,746
-247
| -0.9% | -$10.2K | 0.01% | 1138 |
|
2023
Q4 | $1.17M | Buy |
28,993
+3,358
| +13% | +$136K | 0.01% | 1040 |
|
2023
Q3 | $1M | Sell |
25,635
-5,541
| -18% | -$217K | 0.01% | 991 |
|
2023
Q2 | $1.27M | Buy |
31,176
+6,726
| +28% | +$273K | 0.01% | 867 |
|
2023
Q1 | $1.02M | Buy |
24,450
+1,058
| +5% | +$44.3K | 0.01% | 936 |
|
2022
Q4 | $1.02M | Sell |
23,392
-600
| -3% | -$26.1K | 0.01% | 1046 |
|
2022
Q3 | $931K | Buy |
23,992
+788
| +3% | +$30.6K | 0.01% | 999 |
|
2022
Q2 | $984K | Sell |
23,204
-342
| -1% | -$14.5K | 0.01% | 981 |
|
2022
Q1 | $1.07M | Buy |
23,546
+1,862
| +9% | +$84.8K | 0.01% | 926 |
|
2021
Q4 | $1.05M | Buy |
21,684
+897
| +4% | +$43.5K | 0.01% | 957 |
|
2021
Q3 | $990K | Sell |
20,787
-523
| -2% | -$24.9K | 0.01% | 1022 |
|
2021
Q2 | $1.03M | Buy |
21,310
+1,811
| +9% | +$87.9K | 0.01% | 924 |
|
2021
Q1 | $902K | Sell |
19,499
-4,729
| -20% | -$219K | 0.01% | 921 |
|
2020
Q4 | $1.16M | Buy |
24,228
+6,860
| +39% | +$330K | 0.01% | 800 |
|
2020
Q3 | $744K | Buy |
+17,368
| New | +$744K | 0.01% | 717 |
|